Dr Martin Juneau

Dr Martin Juneau, M.D., FRCP

Cardiologue, directeur de l'Observatoire de la prévention de l'Institut de Cardiologie de Montréal. Professeur titulaire de clinique, Faculté de médecine de l'Université de Montréal. / Cardiologist and Director of Prevention Watch, Montreal Heart Institute. Clinical Professor, Faculty of Medicine, University of Montreal.

Time-restricted feeding: A tool to lose weight and improve cardiometabolic health

15 September 2020
 | 
Dr Martin Juneau, M.D., FRCP

According to a study of obese people, time-restricted feeding, a type of intermittent fasting, can help to lose weight and improve metabolic health, both when eating is limited to a 6-hour as well as 4-hour period.

Chile, an example of aggressive state intervention to combat the obesity epidemic

2 September 2020
 | 
Dr Martin Juneau, M.D., FRCP

In response to the skyrocketing rate of obesity in the Chilean population, the authorities have imposed a law that severely regulates the promotion and sale of ultra-processed industrial products, especially among young people.

Plant-based meat substitutes reduce certain cardiovascular risk factors

1 September 2020
 | 
Dr Martin Juneau, M.D., FRCP

Replacing meat with plant-based meat substitutes significantly decreases certain cardiovascular risk factors according to a randomized, controlled study conducted at Stanford University.

Smoking continues to decline among young people

30 June 2020
 | 
Dr Martin Juneau, M.D., FRCP

The increase in vaping observed in recent years in Canada is associated with a significant decrease in smoking among young people.

The social environment, essential for mental and physical health

15 June 2020
 | 
Dr Martin Juneau, M.D., FRCP

The level of social integration is one of the main predictors of individuals’ health status and life expectancy.

The cardiovascular benefits of soy

28 May 2020
 | 
Dr Martin Juneau, M.D., FRCP

A large study (over 200,000 participants) reports that regular soy consumption is associated with a lower risk of coronary heart disease.

COVID-19 is a disease that also affects blood vessels

27 May 2020
 | 
Dr Martin Juneau, M.D., FRCP

Patients who develop severe complications from COVID-19 often have bleeding disorders leading to abnormal blood clot formation.

Hydroxychloroquine and COVID-19: A potentially harmful effect on the heart

19 May 2020
 | 
Dr Martin Juneau, M.D., FRCP

The results obtained for the treatment of patients with COVID-19 with hydroxychloroquine do not support its use in the current context. This treatment increases the corrected QT interval on the electrocardiogram, a recognized marker of an increased risk of fatal arrhythmias.

Obesity and heart function

14 May 2020
 | 
Dr Martin Juneau, M.D., FRCP

A study sheds light on a mechanism of adaptation for the decrease in cardiac energy capacity induced by obesity.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.